THANK YOU BROTHER, RICIN
One of the outrages of our time is that remdesivir for COVID-19 sailed through the approval process despite all the warning signs, leaving a trail of death. A further outrage is that while former COVID officials are falling all over themselves to put distance between themselves and the follow-the-science edicts now proved utterly false, remdesivir is still here. You can check out the current NIH remdesivir guidelines for the nonhospitalized and hospitalized, last updated February 29, 2024.
Anthony Fauci is scheduled to testify in a public hearing before the House Select Subcommittee on the Coronavirus Pandemic on June 3. While as of this writing the notes from Fauci’s previous closed-door testimony have not yet been released, the key takeaways from it do not mention remdesivir. While members of Congress are itching to nail Fauci on the well-known and well-worn COVID issues such as distancing, mask efficacy, gain-of-function funding, the proximal-origins narrative, oversold vaccines, and now possibly illegal use of a private email address to avoid FOIA embarrassment, I am asking the members to spend some time grilling him on remdesivir in the hope of getting it withdrawn pronto. Here are some questions to consider asking him:
1. The remdesivir trial for Ebola had such an alarmingly high rate of deaths and organ failure it had to be pulled mid-trial. Why did you expect a different outcome when used for COVID-19? In other words, why would high toxicity be unique to Ebola sufferers?
2. Why did you allow Gilead to change the trial’s endpoint from deaths to time to discharge in the middle of the trial when such practice violates clinical trial guidelines?
God Bless You and Your Families!
Love,
Please think about donating below.